Primary Record
1662-06-2
- In stock
- 5,872 g
- Purity
- 98.4 %
- CAS
- 1662-06-2
Compound Identifiers & Properties
- CAS
- 1662-06-2
- PubChem CID
- 107701
- SMILES
- C[C@H]([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O)O
- Canonical SMILES
- C[C@@H](O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C
Names & Synonyms
- 1662-06-2
- (20R)-17,20-Dihydroxypregn-4-en-3-one
- 17-DHP
- 17,20beta-DHP
- Dydrogesterone Impurity 9
- RefChem:1057644
- 17alpha,20beta-Dihydroxy-4-pregnen-3-one
- DTXSID60873499
- 17,20R-dihydroxypregn-4-en-3-one
- 17alpha-Hydroxy-20beta-dihydroprogesterone
- 17alpha,20beta-Dihydroxypregn-4-en-3-one
- CHEBI:36723
- 4-Pregnen-17alpha,20beta-diol-3-one
- 17a,20b-Dihydroxyprogesterone
- 17alpha,20beta-Dihydroxyprogesterone
- MASCESDECGBIBB-FSHQYNQFSA-N
- 4-Pregnen-17a,20b-diol-3-one
- AC1L32L4
- orb1693334
- Pregn-4-en-3-one, 17,20-dihydroxy-, (20R)-
- SCHEMBL7063502
- C21H32O3
- 4-Pregnen-17?,20?-diol-3-one
- 17|A,20|A-dihydroxyprogesterone
- DTXCID401477860
- 17,20beta-dihydroxypregn-4-en-3-one
- ZINC6037056
- 17a-hydroxy-20b-dihydroprogesterone
- 1266AH
- 17,20-Dihydroxy-4-pregnen-3-one
- CID107701
- LMST02030149
- MFCD00010485
- 17|A,20|A-Dihydroxy-4-pregnen-3-one
- 17a,20b-Dihydroxy-4-pregnen-3-one
- 4-Pregnen-17|A,20|A-diol-3-one
- AKOS040755520
- C21-H32-O3
- CID:107701
- FP27153
- HY-W587733
- 17 alpha,20 beta-dihydroxyprogesterone
- 17,20beta-Dihydroxy-4-pregnen-3-one
- 17a, 20b-Dihydroxy-4-pregnen-3-one
- 17,20alpha-Dihydroxypregna-4-ene-3-one
- DA-59472
- PD018027
- 17??,20??-Dihydroxy-4-pregnen-3-one
- 17alpha, 20beta-DIHYDROXYPROGESTERONE
- SID:152186768
- J366.144J
- 17alpha, 20beta-Dihydroxy-4-pregnen-3-one
- 4-Pregnen-17 alpha ,20 beta -diol-3-one
- CS-0643585
- FT-0619431
- 17 alpha,20 beta-dihydroxypregn-4-en-3-one
- C04518
- G76987
- (20R)-17alpha,20-Dihydroxypregn-4-en-3-one
- (8R,9S,10R,13S,14S,17R)-17-hydroxy-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- C021012
- F555357
- Q27116937
- 17alpha,20beta-Dihydroxy-4-pregnen-3-one, crystalline
- (1R,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-1-[(1R)-1-hydroxyethyl]-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
- (1R,3aS,3bR,9aR,9bS,11aS)-1-hydroxy-1-[(1R)-1-hydroxyethyl]-9a,11a-dimethyl-2H,3H,3aH,3bH,4H,5H,8H,9H,9bH,10H,11H-cyclopenta[a]phenanthren-7-one
- (8R,9S,10R,13S,14S,17R)-17-hydroxy-17-((R)-1-hydroxyethyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
- Pregn-4-en-3-one, 17,20-dihydroxy-, (20R)-; Pregn-4-en-3-one, 17,20ss-dihydroxy- (7CI,8CI); (20R)-17,20-Dihydroxypregn-4-en-3-one; 17,20ss-DHP; 17,20ss-Dihydroxypregn-4-en-3-one; 17,20ss-Dihydroxyprogesterone; 17a,20ss-Dihydroxy-4-pregnen-3-one; 17a,20ss-Dihydroxyprogesterone; 17a-Hydroxy-20ss-dihydroprogesterone; MIH; Maturation-inducing hormone